ロード中...
Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance
CONTEXT: Glucagon-like peptide-1 (GLP-1) agonists control postprandial glucose and lipid excursion in type 2 diabetes; however, the mechanisms are unclear. OBJECTIVE: To determine the mechanisms of postprandial lipid and glucose control with lixisenatide (GLP-1 analog) in type 2 diabetes. DESIGN: Ra...
保存先:
| 出版年: | J Clin Endocrinol Metab |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Endocrine Society
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6300412/ https://ncbi.nlm.nih.gov/pubmed/30215735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-01176 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|